SCHEMBL29939233

SCHEMBL29939233

O=C(O)N1CCN(c2ccc(CNCCc3ccccc3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ MAPT P10636 7/20 0.53
▸ GAA P10253 4/20 0.53
▸ GFER P55789 2/20 0.53
▸ TP53 P04637 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ ALOX12 P18054 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ ME2 P23368 2/20 0.52
▸ ME1 P48163 2/20 0.52
▸ ME3 Q16798 2/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ NPC1 O15118 2/20 0.52
▸ MEN1 O00255 6/20 0.51
▸ KMT2A Q03164 6/20 0.51
▸ ATM Q13315 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ HTR2A P28223 1/20 0.48
▸ HTR2C P28335 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29939675 0.87 MAPT (0.50) ALDH1A1KDM4EMAPTGAAMAPK1
SCHEMBL24641500 0.84 SMN1; SMN2 (0.59) ALDH1A1MAPTGAAGFERALOX15
SCHEMBL29939249 0.83 MAPT (0.61) ALDH1A1KDM4EMAPTGAAGFER
SCHEMBL24641978 0.82 MAPT (0.56) MAPTGAANPC1HTR2AHTR2C
SCHEMBL24641663 0.81 MAPT (0.57) ALDH1A1KDM4EMAPTGAASMN1; SMN2
SCHEMBL29939879 0.81 KMT2A (0.60) MAPTGAAMEN1KMT2ALMNA
SCHEMBL19210942 0.79 SMN1; SMN2 (0.56) ALDH1A1MAPTGAAGFERTP53
SCHEMBL16026436 0.77 NCF1 (0.57) ALDH1A1KDM4EMAPTGAAGFER
SCHEMBL19212263 0.76 SMN1; SMN2 (0.49) ALDH1A1MAPTGAAGFERTP53
Bicarbonate SCHEMBL11575509 0.76 GAA (0.80) ALDH1A1KDM4EMAPTGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022218440-A1 FXR REGULATOR, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 青岛睿吉医疗技术有限公司 2022-10-20 — — WO disclosed
Send feedback